pyrazines has been researched along with Caliciviridae Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Miao, Z; Pan, Q; Peppelenbosch, MP; Wang, Y; Yu, P | 1 |
| Atkinson, C; Breuer, J; Brown, LK; Burns, SO; Goldstein, R; Jacobs, M; Lowe, DM; Roy, S; Ruis, C; Williams, R; Yara-Romero, E | 1 |
| Arias, A; Goodfellow, I; Thorne, L | 1 |
| Neyts, J; Rocha-Pereira, J; Van Dycke, J | 1 |
4 other study(ies) available for pyrazines and Caliciviridae Infections
| Article | Year |
|---|---|
2'-Fluoro-2'-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705.
Topics: Amides; Animals; Antiviral Agents; Caliciviridae Infections; Cell Line; Deoxycytidine; Humans; Mice; Mycophenolic Acid; Norovirus; Pyrazines; RAW 264.7 Cells; Ribavirin; Virus Replication | 2020 |
Mutagenesis in Norovirus in Response to Favipiravir Treatment.
Topics: Amides; Antiviral Agents; Caliciviridae Infections; Chronic Disease; Common Variable Immunodeficiency; Diarrhea; Fatal Outcome; Humans; Male; Middle Aged; Mutagenesis; Norovirus; Pyrazines | 2018 |
Favipiravir elicits antiviral mutagenesis during virus replication in vivo.
Topics: Amides; Animals; Antiviral Agents; Caliciviridae Infections; Cells, Cultured; Feces; Male; Mice, Inbred C57BL; Mutagenesis; Mutation Rate; Norovirus; Pyrazines; Ribavirin; RNA, Viral; Serial Passage; Virus Replication | 2014 |
Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.
Topics: Amides; Animals; Caliciviridae Infections; Cytidine; Disease Models, Animal; Feces; Gastroenteritis; Mice; Mice, Knockout; Norovirus; Pyrazines; Receptors, Interferon; Transplant Recipients; Virus Shedding | 2015 |